Ipamorelin Cancer Risk Signal Review: What the Evidence Actually Shows
A physician-level review of ipamorelin acetate and cancer risk, covering IGF-1 biology, preclinical data, clinical evidence gaps, and how to screen patients before prescribing.
8 source-based articles maintained by the HealthRX.com Editorial Team.

Showing 8 of 8 clinical reviews.
A physician-level review of ipamorelin acetate and cancer risk, covering IGF-1 biology, preclinical data, clinical evidence gaps, and how to screen patients before prescribing.
A clinician-level review of ipamorelin acetate and its effects on cognitive function, covering GH/IGF-1 pathways, neuroprotection research, dosing protocols, and what patients using GH secretagogues can realistically expect.
A citation-dense guide to how ipamorelin acetate affects hair growth and skin quality, covering IGF-1 signaling, collagen synthesis, clinical data, dosing, and what to realistically expect.
A detailed look at how ipamorelin acetate affects liver function, including ALT/AST changes, IGF-1 signaling through hepatocytes, relevant clinical data, and monitoring protocols for patients on GH secretagogue therapy.
A guide to what happens when you stop ipamorelin, including GH axis rebound, symptom timelines, withdrawal data, and clinical restart protocols from the HealthRX.com medical team.
A physician-level review of ipamorelin acetate and kidney health, covering GH/IGF-1 renal physiology, preclinical protection signals, risk factors for GH-axis hyperfiltration, dosing considerations, and what to monitor before and during use.
A deep clinical review of how ipamorelin acetate alters sleep architecture, slow-wave sleep, and GH pulse timing. Includes trial data, dosing guidance, and analysis.
A week-by-week breakdown of what happens during the first four weeks on ipamorelin acetate, covering sleep, body composition, GH pulse data, and dosing protocols.